ECSP077182A - Metodos para el tratamiento de infecciones endobronquiales - Google Patents

Metodos para el tratamiento de infecciones endobronquiales

Info

Publication number
ECSP077182A
ECSP077182A EC2007007182A ECSP077182A ECSP077182A EC SP077182 A ECSP077182 A EC SP077182A EC 2007007182 A EC2007007182 A EC 2007007182A EC SP077182 A ECSP077182 A EC SP077182A EC SP077182 A ECSP077182 A EC SP077182A
Authority
EC
Ecuador
Prior art keywords
treatment
methods
endobronchial
endobronchial infections
patient
Prior art date
Application number
EC2007007182A
Other languages
English (en)
Inventor
Peter Challoner
Carlos Rodriguez
Thomas E Tarara
John D Lord
Original Assignee
Nektar Therapeutics
Novartis Vaccines & Diagnostic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics, Novartis Vaccines & Diagnostic Inc filed Critical Nektar Therapeutics
Publication of ECSP077182A publication Critical patent/ECSP077182A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención provee métodos para el tratamiento de una infección endobronquial en un paciente a través de la administración al sistema endobronquial del paciente de una composición en aerosol de polvo seco que comprende de 90 a 130 mg de un antibiótico de aminoglicósido de una a tres veces al día durante un primer período de tratamiento de 20 a 36 días.
EC2007007182A 2004-06-18 2007-01-18 Metodos para el tratamiento de infecciones endobronquiales ECSP077182A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58084804P 2004-06-18 2004-06-18

Publications (1)

Publication Number Publication Date
ECSP077182A true ECSP077182A (es) 2007-05-30

Family

ID=35782127

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2007007182A ECSP077182A (es) 2004-06-18 2007-01-18 Metodos para el tratamiento de infecciones endobronquiales

Country Status (25)

Country Link
US (3) US20080214481A1 (es)
EP (1) EP1765288B1 (es)
JP (3) JP2008503500A (es)
KR (2) KR20070026604A (es)
CN (1) CN101014320B (es)
AU (1) AU2005258078B2 (es)
BR (1) BRPI0512146A (es)
CA (1) CA2570976C (es)
DK (1) DK1765288T3 (es)
EC (1) ECSP077182A (es)
ES (1) ES2399279T3 (es)
HR (1) HRP20130076T1 (es)
IL (1) IL179873A (es)
MA (1) MA28740B1 (es)
MX (1) MXPA06014567A (es)
NO (1) NO338799B1 (es)
NZ (1) NZ552047A (es)
PL (1) PL1765288T3 (es)
PT (1) PT1765288E (es)
RU (1) RU2389477C2 (es)
SG (1) SG153833A1 (es)
SI (1) SI1765288T1 (es)
TN (1) TNSN06420A1 (es)
WO (1) WO2006002178A1 (es)
ZA (1) ZA200700420B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2468958C (en) * 2001-12-19 2012-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
USD914881S1 (en) 2003-11-05 2021-03-30 Abbott Diabetes Care Inc. Analyte sensor electronic mount
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US7697967B2 (en) 2005-12-28 2010-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US7883464B2 (en) 2005-09-30 2011-02-08 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US10226207B2 (en) 2004-12-29 2019-03-12 Abbott Diabetes Care Inc. Sensor inserter having introducer
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
CA2665764C (en) * 2006-10-11 2015-05-26 Laboratoires Smb S.A. Pharmaceutical anti-infective composition for inhalation
EP1938822A1 (en) * 2006-12-21 2008-07-02 Novartis AG Combination therapy for the treatment of airways disease
MX2010012452A (es) 2008-05-15 2011-03-15 Novartis Ag Star Suministro pulmonar de una fluoro-quinolona.
US20100198034A1 (en) 2009-02-03 2010-08-05 Abbott Diabetes Care Inc. Compact On-Body Physiological Monitoring Devices and Methods Thereof
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
TWI695723B (zh) * 2009-05-29 2020-06-11 美商沛爾醫療股份有限公司 用於經由呼吸道輸送活性劑的組成物以及相關方法與系統
AU2010286917B2 (en) 2009-08-31 2016-03-10 Abbott Diabetes Care Inc. Medical devices and methods
JP5878475B2 (ja) * 2009-12-14 2016-03-08 シエシー ファルマセウティチィ ソシエタ ペル アチオニ 吸入用抗生物質微粒子
EP2552532A1 (en) 2010-03-24 2013-02-06 Abbott Diabetes Care, Inc. Medical device inserters and processes of inserting and using medical devices
US11064921B2 (en) 2010-06-29 2021-07-20 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US9572774B2 (en) 2011-05-19 2017-02-21 Savara Inc. Dry powder vancomycin compositions and associated methods
US10471083B2 (en) 2011-07-12 2019-11-12 Savara Inc. Formulations of aminoglycoside and fosfomycin in combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
US8826904B2 (en) 2011-07-12 2014-09-09 Cardeas Pharma Corporation Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
NL2009963C2 (en) 2011-12-11 2013-11-11 Abbott Diabetes Care Analyte sensor devices, connections, and methods.
WO2014055456A1 (en) * 2012-10-07 2014-04-10 Abbott Diabetes Care Inc. Medical device insertion indicators
CN102949379B (zh) * 2012-11-14 2014-11-05 中山大学 硫酸奈替米星吸入粉雾剂及其制备方法
US20140275517A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
EP3294134B1 (en) 2015-05-14 2020-07-08 Abbott Diabetes Care Inc. Inserter system for a compact medical device and corresponding method
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
WO2018136898A1 (en) 2017-01-23 2018-07-26 Abbott Diabetes Care Inc. Systems, devices and methods for analyte sensor insertion
WO2020163416A1 (en) * 2019-02-05 2020-08-13 Mylan Inc Devices and methods for tobramycin inhalation treatment
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
USD999913S1 (en) 2020-12-21 2023-09-26 Abbott Diabetes Care Inc Analyte sensor inserter

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2224175B1 (es) 1973-04-04 1978-04-14 Isf Spa
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1017153B (it) 1974-07-15 1977-07-20 Isf Spa Apparecchio per inalazioni
SE438261B (sv) 1981-07-08 1985-04-15 Draco Ab Anvendning i dosinhalator av ett perforerat membran
GB8314308D0 (en) 1983-05-24 1983-06-29 Matburn Holdings Ltd Medical administration devices
US4805811A (en) 1985-03-29 1989-02-21 Aktiebolaget Draco Dosage device
SE448277B (sv) 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
GB8909891D0 (en) 1989-04-28 1989-06-14 Riker Laboratories Inc Device
IT1243344B (it) 1990-07-16 1994-06-10 Promo Pack Sa Inalatore plurimonodose per medicamenti in polvere
DE69233690T2 (de) 1991-07-02 2008-01-24 Nektar Therapeutics, San Carlos Abgabevorrichtung für nebelförmige Medikamente
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
US5388572A (en) 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
CN1073119C (zh) 1994-05-18 2001-10-17 吸入治疗系统公司 干扰素干粉配方的方法及组合物
CN1131080C (zh) 1994-09-21 2003-12-17 吸入治疗系统 用于喷洒干的粉末药物的方法和装置
US5522385A (en) 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
CA2218074C (en) 1995-04-14 2002-10-08 Mohammed Eljamal Powdered pharmaceutical formulations having improved dispersibility
US5826633A (en) 1996-04-26 1998-10-27 Inhale Therapeutic Systems Powder filling systems, apparatus and methods
SI20959A (sl) * 1998-12-17 2003-02-28 Pathogenesis Corporation Metoda za zdravljenje hudega kroničnega bronhitisa (bronhiektazije) z aerosoliziranimi antibiotiki
CA2382821A1 (en) 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US6586008B1 (en) 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
US7442388B2 (en) 2000-05-10 2008-10-28 Weers Jeffry G Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
ATE322249T1 (de) 2001-05-18 2006-04-15 Chiron Corp System zur abgabe einer tobramycin-formulierung
DE10131917A1 (de) 2001-07-02 2003-01-23 Infineon Technologies Ag Verfahren zur Erzeugung einer stufenförmigen Struktur auf einem Substrat
WO2003041776A1 (en) 2001-11-14 2003-05-22 Nektar Therapeutics Aerosolization apparatus comprising connectable body and endpiece
US20030094173A1 (en) 2001-11-14 2003-05-22 Inhale Therapeutic Systems, Inc. Aerosolization device with improved endpiece connection
CA2468958C (en) * 2001-12-19 2012-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
AU2002351271A1 (en) 2001-12-21 2003-07-24 Nektar Therapeutics Capsule package with moisture barrier
EP1501479A1 (en) 2002-05-07 2005-02-02 Nektar Therapeutics Capsules for dry powder inhalers and methods of making and using same
CN1493297A (zh) * 2003-09-13 2004-05-05 南昌弘益科技有限公司 妥布霉素吸入粉雾剂及其制备方法

Also Published As

Publication number Publication date
CA2570976C (en) 2013-08-13
CN101014320A (zh) 2007-08-08
NO20070253L (no) 2007-03-13
JP2013056947A (ja) 2013-03-28
PT1765288E (pt) 2013-01-29
WO2006002178A1 (en) 2006-01-05
SG153833A1 (en) 2009-07-29
IL179873A0 (en) 2007-05-15
BRPI0512146A (pt) 2008-02-12
MXPA06014567A (es) 2007-07-24
ES2399279T3 (es) 2013-03-27
US20120148641A1 (en) 2012-06-14
EP1765288A1 (en) 2007-03-28
AU2005258078B2 (en) 2010-09-30
JP2008503500A (ja) 2008-02-07
NO338799B1 (no) 2016-10-24
US20110097412A1 (en) 2011-04-28
EP1765288A4 (en) 2009-05-13
KR20070026604A (ko) 2007-03-08
PL1765288T3 (pl) 2013-04-30
TNSN06420A1 (en) 2008-02-22
US8664187B2 (en) 2014-03-04
HRP20130076T1 (hr) 2013-03-31
CN101014320B (zh) 2011-05-18
KR20120131245A (ko) 2012-12-04
US20080214481A1 (en) 2008-09-04
RU2389477C2 (ru) 2010-05-20
SI1765288T1 (sl) 2013-02-28
IL179873A (en) 2014-09-30
NZ552047A (en) 2009-11-27
CA2570976A1 (en) 2006-01-05
RU2007101906A (ru) 2008-07-27
AU2005258078A1 (en) 2006-01-05
EP1765288B1 (en) 2012-11-07
JP2012107047A (ja) 2012-06-07
MA28740B1 (fr) 2007-07-02
ZA200700420B (en) 2008-05-28
DK1765288T3 (da) 2013-02-11

Similar Documents

Publication Publication Date Title
ECSP077182A (es) Metodos para el tratamiento de infecciones endobronquiales
NO20063105L (no) Anordning og fremgangsmate for administrering av terapeutiske midler
ECSP099451A (es) Compuestos de urea policíclicos antibacterianos
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
CU23367A3 (es) Formulación de moxifloxacino con sal común
CY1114363T1 (el) Ανθελμινθικος συνδυασμος
UY31106A1 (es) Formulaciones que contienen triazinonas y hierro
UA94901C2 (ru) Антибактериальные производные пиперидина
DOP2020000058A (es) Compuestos monobactámicos cromanos para el tratamiento de infecciones bacterianas
CL2007001427A1 (es) Sal de maleato de 5-amino-3-(2',3'-di-o-acetil-beta-d-ribofuranosil)-3h-tiazolo[4,5-d]pirimidin-2-ona; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de una infeccion po
CL2012001080A1 (es) Dispersión sólida de rifaximina y un portador farmacéuticamente aceptable; composición farmacéutica; uso en el tratarmiento y/o prevención de una infecciíon microbiana que comprende la administración de la dipersión sólida.
CR8569A (es) Inhibidores de integrasa de vih
WO2006093784A3 (en) Dosage forms of antibiotics and combinations of antibiotics ans symptomatic relief agents
NO20083250L (no) Antibakterielle pyrrolopyridiner, pyrrolopyrimidiner og pyrroloazepiner
HK1141980A1 (en) Use of carrageenan for treating rhinovirus infections
BRPI0916885B8 (pt) composição farmacêutica
ECSP045397A (es) 6-ALQUILIDEN-PENEMS BICÍCLICOS COMO INHIBIDORES DE LAS b-LACTAMASAS
WO2005030109A3 (en) Regimen for the administration of rifamycin-class antibiotics
CL2007001910A1 (es) Compuestos derivados de penem; composicion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
ECSP045405A (es) Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa
GT200600331A (es) Inhibidores de 6-alquiliden-penem-beta-lactamasa biciclicos y combinacion de antibioticos de beta-lactama: un antibiotico de amplio espectro.
BRPI0519752A2 (pt) compostos peptÍdicos
GT200600332A (es) Inhibidores de 6-alquiliden-penem beta-lactamasa triciclicos y combinación de antibióticos de b-lactama: un antibiotico de amplio espectro
ATE311885T1 (de) Monobactam-antibakterielle verbindungen und anwendungsverfahren
CY1113562T1 (el) Σκευασματα τομπραμυκινης για τη θεραπεια ενδοβρογχικων λοιμωξεων